IPO Trending
JFLLIFESME / NSEListed

JFL Life Sciences Limited

JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.

₹61 - ₹618.93x sub
GMPFlat
Est. Listing Price₹61
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.